2012 Germany Molecular Diagnostics Market Outlook: Growth Opportunities and Strategies


April 23, 2012
850 Pages - SKU: VPG3869152
License type:
Countries covered: Germany

This report presents a comprehensive analysis of the German molecular diagnostics market, including:
  • Major issues pertaining to the German molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:
- Infectious Diseases- Genetic Diseases- Cancer- Paternity Testing/HLA Typing- Forensic Testing
  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.
Contains 850 pages and 36 tables

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.



More Diagnostics reports by Venture Planning Group

2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers by Venture Planning Group
This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, ...
2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices by Venture Planning Group
This new 262-page report from Venture Planning Group provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, ...
2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs by Venture Planning Group
This new 260-page report from Venture Planning Group provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, ...
2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers by Venture Planning Group
This new 260-page report from Venture Planning Group provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, ...
See all reports like this >>

More Germany Diagnostics reports

2013 Drugs of Abuse Testing in Germany: Hospitals, Commercial Labs, Physician Offices by Venture Planning Group
This new 262-page report from Venture Planning Group provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation, ...
2013 Endocrine Function Testing Market in Germany: Hospitals, Commercial Labs, Physician Offices by Venture Planning Group
This new 271-page report from Venture Planning Group provides a comprehensive analysis in the German endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts ...
2013 Therapeutic Drug Monitoring (TDM) Market in Germany: Hospitals, Commercial Labs, Physician Offices by Venture Planning Group
This new 249-page report from Venture Planning Group provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales ...
2013 Immunoprotein Diagnostic Testing in Germany: Hospitals, Commercial Labs, Physician Offices by Venture Planning Group
This new 236-page report from Venture Planning Group provides analysis of the German immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, ...
See all reports like this >>

More Germany reports

D&B Country RiskLine Report: Germany by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Germany by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>